DE69718168D1 - Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv - Google Patents

Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv

Info

Publication number: DE69718168D1
Authority: DE; Germany
Prior art keywords: zidovudine; hiv; treatment; compositions containing; compositions
Prior art date: 1996-06-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69718168T

Other languages

English (en)

Other versions

DE69718168T2 (de

Inventor

Clair Heider St

Walter Barry

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-25

Filing date

1997-06-23

Publication date

2003-02-06

1996-07-04 Priority claimed from GBGB9614024.9A external-priority patent/GB9614024D0/en

1997-06-23 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2003-02-06 Application granted granted Critical

2003-02-06 Publication of DE69718168D1 publication Critical patent/DE69718168D1/de

2003-10-23 Publication of DE69718168T2 publication Critical patent/DE69718168T2/de

2017-06-24 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

DE69718168T 1996-06-25 1997-06-23 Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv Expired - Fee Related DE69718168T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US2217896P	1996-06-25	1996-06-25
GBGB9614024.9A GB9614024D0 (en)	1996-07-04	1996-07-04	Antiviral therapeutic combinations
PCT/EP1997/003246 WO1997049410A1 (en)	1996-06-25	1997-06-23	Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv

Publications (2)

Publication Number	Publication Date
DE69718168D1 true DE69718168D1 (de)	2003-02-06
DE69718168T2 DE69718168T2 (de)	2003-10-23

Family

ID=26309631

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69718168T Expired - Fee Related DE69718168T2 (de)	1996-06-25	1997-06-23	Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv

Country Status (26)

Country	Link
US (1)	US6486136B1 (de)
EP (1)	EP0910386B1 (de)
KR (1)	KR20000022225A (de)
CN (1)	CN1306430A (de)
AP (1)	AP9801418A0 (de)
AT (1)	ATE230267T1 (de)
AU (1)	AU723877C (de)
BR (1)	BR9709951A (de)
CA (1)	CA2262765A1 (de)
CO (1)	CO4910137A1 (de)
CZ (1)	CZ429398A3 (de)
DE (1)	DE69718168T2 (de)
EA (1)	EA001457B1 (de)
ES (1)	ES2189964T3 (de)
HU (1)	HUP9903098A3 (de)
ID (1)	ID18739A (de)
IL (1)	IL127350A0 (de)
IS (1)	IS4913A (de)
NO (1)	NO986035L (de)
NZ (1)	NZ333098A (de)
PE (1)	PE87398A1 (de)
PL (1)	PL330791A1 (de)
TR (1)	TR199802703T2 (de)
WO (1)	WO1997049410A1 (de)
YU (1)	YU58498A (de)
ZA (1)	ZA975565B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY115461A (en)	1995-03-30	2003-06-30	Wellcome Found	Synergistic combinations of zidovudine, 1592u89 and 3tc
AU8017298A (en) *	1997-05-17	1998-12-11	Glaxo Group Limited	Antiviral combinations containing the carbocyclic nucleoside 1592u89
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt
GB9802472D0 (en) *	1998-02-06	1998-04-01	Glaxo Group Ltd	Pharmaceutical compositions
US6194391B1 (en) *	1998-06-24	2001-02-27	Emory University	3′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4724232A (en) *	1985-03-16	1988-02-09	Burroughs Wellcome Co.	Treatment of human viral infections
MY104575A (en) *	1989-12-22	1994-04-30	The Wellcome Foundation Ltd	Therapeutic nucleosides.
GB9104740D0 (en) *	1991-03-06	1991-04-17	Wellcome Found	Antiviral nucleoside combination
GB9307013D0 (en) *	1993-04-02	1993-05-26	Wellcome Found	Therapeutic combinations
IS2334B (is) *	1992-09-08	2008-02-15	Vertex Pharmaceuticals Inc., (A Massachusetts Corporation)	Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) *	1992-09-08	1998-03-03	Vertex Pharmaceuticals Incorporated	THF-containing sulfonamide inhibitors of aspartyl protease
UA49803C2 (uk) *	1994-06-03	2002-10-15	Дж.Д. Сьорль Енд Ко	Спосіб лікування ретровірусних інфекцій
US5646180A (en) *	1995-12-05	1997-07-08	Vertex Pharmaceuticals Incorporated	Treatment of the CNS effects of HIV

1997
- 1997-06-23 HU HU9903098A patent/HUP9903098A3/hu unknown
- 1997-06-23 DE DE69718168T patent/DE69718168T2/de not_active Expired - Fee Related
- 1997-06-23 KR KR1019980710645A patent/KR20000022225A/ko not_active Application Discontinuation
- 1997-06-23 PE PE1997000535A patent/PE87398A1/es not_active Application Discontinuation
- 1997-06-23 EA EA199801046A patent/EA001457B1/ru not_active IP Right Cessation
- 1997-06-23 BR BR9709951A patent/BR9709951A/pt not_active IP Right Cessation
- 1997-06-23 AT AT97928262T patent/ATE230267T1/de not_active IP Right Cessation
- 1997-06-23 WO PCT/EP1997/003246 patent/WO1997049410A1/en active Search and Examination
- 1997-06-23 EP EP97928262A patent/EP0910386B1/de not_active Expired - Lifetime
- 1997-06-23 PL PL97330791A patent/PL330791A1/xx unknown
- 1997-06-23 AU AU32626/97A patent/AU723877C/en not_active Ceased
- 1997-06-23 CO CO97034780A patent/CO4910137A1/es unknown
- 1997-06-23 ZA ZA975565A patent/ZA975565B/xx unknown
- 1997-06-23 CZ CZ984293A patent/CZ429398A3/cs unknown
- 1997-06-23 CN CN97197356A patent/CN1306430A/zh active Pending
- 1997-06-23 ID IDP972146A patent/ID18739A/id unknown
- 1997-06-23 AP APAP/P/1998/001418A patent/AP9801418A0/en unknown
- 1997-06-23 US US09/202,674 patent/US6486136B1/en not_active Expired - Fee Related
- 1997-06-23 TR TR1998/02703T patent/TR199802703T2/xx unknown
- 1997-06-23 CA CA002262765A patent/CA2262765A1/en not_active Abandoned
- 1997-06-23 ES ES97928262T patent/ES2189964T3/es not_active Expired - Lifetime
- 1997-06-23 IL IL12735097A patent/IL127350A0/xx unknown
1998
- 1998-11-30 IS IS4913A patent/IS4913A/is unknown
- 1998-12-16 YU YU58498A patent/YU58498A/sr unknown
- 1998-12-18 NZ NZ333098A patent/NZ333098A/en unknown
- 1998-12-22 NO NO986035A patent/NO986035L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1997049410A1 (en)	1997-12-31
IL127350A0 (en)	1999-10-28
EA199801046A1 (ru)	1999-08-26
NO986035D0 (no)	1998-12-22
AP9801418A0 (en)	1998-12-31
DE69718168T2 (de)	2003-10-23
AU723877B2 (en)	2000-09-07
CA2262765A1 (en)	1997-12-31
PE87398A1 (es)	1999-01-15
ZA975565B (en)	1998-12-23
ES2189964T3 (es)	2003-07-16
BR9709951A (pt)	1999-08-10
US6486136B1 (en)	2002-11-26
EP0910386B1 (de)	2003-01-02
NO986035L (no)	1999-02-23
AU723877C (en)	2001-08-23
EA001457B1 (ru)	2001-04-23
AU3262697A (en)	1998-01-14
EP0910386A1 (de)	1999-04-28
IS4913A (is)	1998-11-30
KR20000022225A (ko)	2000-04-25
CO4910137A1 (es)	2000-04-24
NZ333098A (en)	2000-08-25
HUP9903098A2 (hu)	1999-12-28
TR199802703T2 (xx)	1999-03-22
HU9903098D0 (en)	1999-10-28
HUP9903098A3 (en)	2000-01-28
ID18739A (id)	1998-05-07
PL330791A1 (en)	1999-06-07
CZ429398A3 (cs)	1999-05-12
YU58498A (en)	1999-11-22
CN1306430A (zh)	2001-08-01
ATE230267T1 (de)	2003-01-15

Similar Documents

Publication	Publication Date	Title
ATE284953T1 (de)	2005-01-15	Zusammensetzung zur reduzierung von schlechten gerüchen enthaltend eine laccase
ATE270556T1 (de)	2004-07-15	Verwendung von synergistischen zusammensetzungen von il-12 und ifn-alpha für die behandlung von infektiösen krankheiten
DE69826811D1 (de)	2004-11-11	Zusammensetzungen für die Verwendung bei der Behandlung und Prävention von Hyperurikämie
DE3579113D1 (de)	1990-09-13	Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE69008048D1 (de)	1994-05-19	Duftzusammensetzungen und ihre Verwendung in Reinigungsmitteln.
ATE110556T1 (de)	1994-09-15	Verbesserungen bei der behandlung von zähnen.
ATE212218T1 (de)	2002-02-15	Topische zusammensetzungen mit verbessertem hautgefühl
DE69718053D1 (de)	2003-01-30	in vitro methoden und verwendung von pharmazeutische zusammensetzungen für die BEHANDLUNG VON INNENOHRHAARZELLEN
DE69941566D1 (de)	2009-12-03	N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE69911312D1 (de)	2003-10-23	Eisenoxidnanopigmente enthaltende Zusammensetzungen für die künstliche Bräunung der Haut und andere Verwendungen
DE69822919D1 (de)	2004-05-13	Spezifische Antikörper zur Verwendung in der Herstellung pharmazeutischer Zusammensetzungen nützlich für die Vorbeugung oder Behandlung von Gastritis, Magen- und Zwölffingerdarmgeschwüren
TR199901172T2 (xx)	1999-08-23	Yeni ikame edilmi� pirazol t�revleri.
ATE214274T1 (de)	2002-03-15	Antikonvulsiva zur verwendung bei der behandlung von amyotropischer lateralsklerose
DE59603216D1 (de)	1999-11-04	Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege
DE3870508D1 (de)	1992-06-04	Zusammensetzung zur behandlung des haares.
DE69008342D1 (de)	1994-05-26	Orthese für die Behandlung von Schienbeinverdrehungen bei Kindern.
DE69924375D1 (de)	2005-04-28	Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
DE69827633D1 (de)	2004-12-23	Oxidationszusammensetzung und verwendungen derselben für die behandlung von keratinischen fasern
ATE257708T1 (de)	2004-01-15	Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
DE69831334T2 (de)	2006-06-14	Oxydierungszusammensetzung zur anwendung in der behandlung von keratinischen fasern
DE69405919D1 (de)	1997-11-06	Zusammensetzungen zur Behandlung von Keratinfasern
PL316656A1 (en)	1997-02-03	Free halophantrin base for use in treating marsh-fever and compositions containing same
DE3850433D1 (de)	1994-08-04	Allergiebehandlung und Zusammensetzung dafür.
ATE230267T1 (de)	2003-01-15	Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
DE69913380D1 (de)	2004-01-15	Zusammensetzung zur behandlung von periodontalen erkrankungen

Legal Events

Date	Code	Title	Description
2010-04-22	8339	Ceased/non-payment of the annual fee